The document discusses a presentation on prescription drug abuse awareness week. It notes that abusing prescription and over-the-counter drugs can be as dangerous and addictive as street drugs. Every day, 2,500 teens abuse a prescription drug for the first time. Key factors driving teen abuse include misperceptions that medicines are safer than street drugs and easy access from home medicine cabinets or friends. Parents also lack awareness and urgency around prescription drug abuse compared to street drugs. Bold action is needed through education initiatives to address this growing public health crisis.
The document summarizes the results of a survey conducted by the National Association of State Alcohol and Drug Abuse Directors (NASADAD) regarding how state substance abuse agencies are addressing the issue of prescription drug abuse. Key findings include:
- Nearly all states consider prescription drug abuse an important issue.
- The majority of states have an active state task force addressing the problem.
- Many states have passed legislation focused on reducing both supply and demand of prescription drugs.
- Most states conduct public education campaigns around prescription drug abuse.
Have you become your teen's drug dealer? What's in your medicine cabinet?Amanda Edgar
This town hall meeting discussed the abuse of prescription and over-the-counter medications by teens. Recent studies show teen abuse of these drugs is a concern, with most teens getting the drugs from their homes or friends. Data from Maine and the city of Portland was presented showing rates of teen prescription drug abuse. Ways for parents to educate themselves and their children on the dangers of abuse and properly dispose of unused medications were discussed. Local treatment resources were also provided.
Prescription Pain Killers,The Latest Threat to Child WelfareWill Jones
1) The opioid epidemic puts many children at risk of abuse and neglect as parents struggling with addiction may neglect their children or expose them to dangerous situations. The number of children being removed from homes due to parental drug abuse has increased significantly in many states.
2) Prescription drug monitoring programs collect data on opioid prescriptions but it is often not used to its full potential. Linking this prescription data to child welfare records through analytics could help caseworkers identify at-risk children and families earlier.
3) Specific analytics approaches discussed include alerts when a prescription is written for a child in state custody, alerts when a parent is visiting multiple doctors and pharmacies to obtain drugs, and risk scoring to predict higher risk families
The campaign aimed to inform HIV positive and negative gay men in serodiscordant relationships about strategies to maintain health. It was evidence-based and involved community consultation. Research found new HIV infections were more likely in the first six months of such relationships. The campaign sought to normalize serodiscordant relationships, challenge stigma, and provide health information and communication strategies. An evaluation assessed campaign reach, satisfaction, and impact on awareness and knowledge through an online survey and focus groups.
The document summarizes recent trends in teen drug use according to a 2009 study. Key findings of the study include a 67% increase in past year ecstasy use and a 19% increase in past year marijuana use among teens. The study also found declining attitudes among teens against drug use. A new trend of teens mixing prescription cough syrup with soda and candy, called "purpling," is highlighted which can cause overdose and respiratory problems. The document advocates for educators to utilize student drug testing to curb rising teen drug abuse.
This document provides a briefing on COVID-19 for senior company leaders. It begins with an overview of the current global situation, with over 380,000 confirmed cases spreading quickly worldwide. Countries have implemented strict social distancing measures, causing rapid economic declines. Some Asian countries have kept new cases low by aggressive testing and contact tracing as they restart their economies. The document outlines scenarios for how the situation may evolve and provides an executive summary of actions companies can take to address challenges in workforce, cash management, business resiliency and reimagining operations for the future.
This document summarizes a study examining risk factors for overdose death from prescription opioids. The study compared 254 decedents who died from prescription opioid overdoses to 1,308 people who used prescription opioids. It found that decedents were more likely to obtain opioids from non-prescription sources, use them more often than prescribed, have chronic pain, smoke daily, have a history of substance abuse or mental illness, and lack social support. The study aims to help clinicians recognize at-risk patients and control opioid exposure to prevent overdoses.
Opioid addiction is a growing problem that significantly impacts individuals and society. Social workers are on the front lines addressing this issue through clinical work, education, and intervention programs. Research shows there are many triggers that can lead to opioid use, including use of other drugs like tobacco, avoidance of withdrawal symptoms, exposure to peer groups that use drugs, and conditioning of the brain to see drugs as rewarding despite negative consequences. Understanding these triggers is important for social workers to help prevent and intervene in opioid addiction.
The document summarizes the results of a survey conducted by the National Association of State Alcohol and Drug Abuse Directors (NASADAD) regarding how state substance abuse agencies are addressing the issue of prescription drug abuse. Key findings include:
- Nearly all states consider prescription drug abuse an important issue.
- The majority of states have an active state task force addressing the problem.
- Many states have passed legislation focused on reducing both supply and demand of prescription drugs.
- Most states conduct public education campaigns around prescription drug abuse.
Have you become your teen's drug dealer? What's in your medicine cabinet?Amanda Edgar
This town hall meeting discussed the abuse of prescription and over-the-counter medications by teens. Recent studies show teen abuse of these drugs is a concern, with most teens getting the drugs from their homes or friends. Data from Maine and the city of Portland was presented showing rates of teen prescription drug abuse. Ways for parents to educate themselves and their children on the dangers of abuse and properly dispose of unused medications were discussed. Local treatment resources were also provided.
Prescription Pain Killers,The Latest Threat to Child WelfareWill Jones
1) The opioid epidemic puts many children at risk of abuse and neglect as parents struggling with addiction may neglect their children or expose them to dangerous situations. The number of children being removed from homes due to parental drug abuse has increased significantly in many states.
2) Prescription drug monitoring programs collect data on opioid prescriptions but it is often not used to its full potential. Linking this prescription data to child welfare records through analytics could help caseworkers identify at-risk children and families earlier.
3) Specific analytics approaches discussed include alerts when a prescription is written for a child in state custody, alerts when a parent is visiting multiple doctors and pharmacies to obtain drugs, and risk scoring to predict higher risk families
The campaign aimed to inform HIV positive and negative gay men in serodiscordant relationships about strategies to maintain health. It was evidence-based and involved community consultation. Research found new HIV infections were more likely in the first six months of such relationships. The campaign sought to normalize serodiscordant relationships, challenge stigma, and provide health information and communication strategies. An evaluation assessed campaign reach, satisfaction, and impact on awareness and knowledge through an online survey and focus groups.
The document summarizes recent trends in teen drug use according to a 2009 study. Key findings of the study include a 67% increase in past year ecstasy use and a 19% increase in past year marijuana use among teens. The study also found declining attitudes among teens against drug use. A new trend of teens mixing prescription cough syrup with soda and candy, called "purpling," is highlighted which can cause overdose and respiratory problems. The document advocates for educators to utilize student drug testing to curb rising teen drug abuse.
This document provides a briefing on COVID-19 for senior company leaders. It begins with an overview of the current global situation, with over 380,000 confirmed cases spreading quickly worldwide. Countries have implemented strict social distancing measures, causing rapid economic declines. Some Asian countries have kept new cases low by aggressive testing and contact tracing as they restart their economies. The document outlines scenarios for how the situation may evolve and provides an executive summary of actions companies can take to address challenges in workforce, cash management, business resiliency and reimagining operations for the future.
This document summarizes a study examining risk factors for overdose death from prescription opioids. The study compared 254 decedents who died from prescription opioid overdoses to 1,308 people who used prescription opioids. It found that decedents were more likely to obtain opioids from non-prescription sources, use them more often than prescribed, have chronic pain, smoke daily, have a history of substance abuse or mental illness, and lack social support. The study aims to help clinicians recognize at-risk patients and control opioid exposure to prevent overdoses.
Opioid addiction is a growing problem that significantly impacts individuals and society. Social workers are on the front lines addressing this issue through clinical work, education, and intervention programs. Research shows there are many triggers that can lead to opioid use, including use of other drugs like tobacco, avoidance of withdrawal symptoms, exposure to peer groups that use drugs, and conditioning of the brain to see drugs as rewarding despite negative consequences. Understanding these triggers is important for social workers to help prevent and intervene in opioid addiction.
This document summarizes a conference on examining prescription drug abuse across America. It discusses the growth of prescription drug overdose deaths, the impact of non-medical prescription drug use including billions in health care costs, and how prescription drug abuse affects people of all ages. The document outlines a national prescription drug abuse prevention strategy including education, prescription drug monitoring programs, and safe drug disposal. It emphasizes that collaboration between organizations and communities is key to addressing this complex issue.
This document summarizes an education and advocacy track on parents and naloxone presented at a conference. It introduces Joanne Peterson from Learn to Cope, an organization that provides support and resources to families affected by addiction. It outlines the goals of Learn to Cope, including educating communities about drug dangers and solutions. Data is presented showing the large number of people Learn to Cope has helped and its pilot program training parents to distribute naloxone kits has helped reduce overdose deaths in Massachusetts.
Preventing teen abuse of prescriptions and over theraynaandyailka
This document discusses preventing teen abuse of prescription and over-the-counter medications. It outlines a mission and goals to educate stakeholders on risk factors for teen abuse and significantly reduce abuse among teens aged 13-19. Objectives include better understanding trends in teen medication abuse, increasing parent-teen communication, and reducing unattended medications. Statistics show increasing rates of teen prescription drug abuse. Efforts to address the issue include prescription drug monitoring programs, take-back initiatives, and educating parents, physicians, and communities. Challenges include getting families, physicians, and authorities adequately involved in prevention.
National Rx Drug Abuse Summit, April 2-4, 2013. General Session presentation, "Prevention and Prosecution," Frances M. Harding, Director, Center for Substance Abuse Prevention, SAMHSA
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
Community pharmacists are well positioned to help address the growing problem of opioid and benzodiazepine addiction but face challenges. Early identification of at-risk patients, supportive benefit structures, and intervention training could empower pharmacists. While many recognize their responsibility, behavioral engagement in prevention is often lacking due to practice barriers, lack of patient information, and fear of responses. Standardizing communication expectations and screening tools could help pharmacists better fulfill their role on the treatment team.
I understand that I will be assigned a group assistant who will check in with me weekly to discuss my progress and goals. I agree to be honest with my
assistant about my substance use and high-risk behaviors. I understand that my assistant will share information with my treatment team if I disclose plans to harm
myself or others or if I report using substances in a way that puts my health or safety at risk.
Confidentiality I understand that what is said in group stays in group. I will not share other group members’ personal information outside of group. However, I understand
that my group leaders are mandated reporters and will share information with my treatment team or authorities if safety is a concern.
Safety I agree to
I N J U R Y P R E V E N T I O NAnna ValdeWalden UnFo.docxwilcockiris
Prescription drug misuse, especially of opioids and stimulants, is increasing among adolescents. Availability of these drugs has increased dramatically with over 45 million prescriptions for stimulants and over 209 million for opioids being written in 2010. Many teens have access to these drugs from their parents' medicine cabinets. While some believe prescription drugs are safer than illicit drugs, they are a major contributor to drug overdose deaths. Emergency nurses can help by educating patients and communities on proper storage, disposal and risks of misuse, ensuring prescription drug monitoring programs are used, and developing prescribing guidelines.
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine Global Medical Cures™
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
The document outlines state responses to prescription drug and heroin abuse presented at an advocacy track session. It includes presentations from officials in Arizona, Virginia, and New Mexico on their state's strategies. Arizona's presentation focuses on the state's prescriber report cards. Virginia's presentation discusses the governor's task force recommendations and a new health and criminal justice data committee. New Mexico's presentation describes the state's high overdose rates and model of stakeholder collaboration to reduce overdose deaths.
The document summarizes key findings from a survey of over 1,600 young adults aged 18-25 on trends in prescription stimulant misuse and abuse. Some of the main findings include:
- 17% of respondents reported misusing or abusing prescription stimulants without a valid prescription. Rates were higher among college students (20%) than non-students (15%).
- Motivations for misuse included improving academic or work performance and staying awake. Misuse was also connected to managing social and busy lifestyles.
- The majority of misusers sourced stimulants from friends who had valid prescriptions. Over half of prescribed respondents reported being asked to share or sell their medication.
Critique of Australian National Drugs Campaign (Media Effectiveness Research)AzmiSuhaimi
The National Drugs Campaign by the Australian Government aimed to reduce illicit drug use among young Australians over 10 years through 4 phases targeting youths and parents. Phase 3 (2007) built on earlier phases and targeted youths aged 13-24, parents of 8-17 year olds, and social organizations. Formative research involved surveys and literature review on drug harms. The outreach strategy used TV, print, and online ads plus booklets. Evaluative surveys found high campaign awareness and recognition among youths and parents, and that it influenced attitudes and increased parent-child drug discussions. Critiques noted the research relied heavily on past data and some target groups were not addressed or evaluated.
The document discusses the growing heroin addiction epidemic in the United States. It notes that prescription opioid misuse has led many Americans to turn to heroin and that overdose deaths have more than tripled since 2010. It provides information on prevention and treatment efforts, including expanding access to the overdose reversal drug naloxone and increasing medically-assisted treatment programs. The document also discusses Walgreens' efforts to install safe drug disposal kiosks and make naloxone available without a prescription to help address the crisis.
This document provides a summary of a presentation on translating the science on marijuana into effective public health messages. The presentation aimed to understand the latest science on marijuana use and how to frame prevention messages. It identifies concerns related to marijuana use and legalization such as addiction, impaired driving, and negative impacts on adolescent brain development and academic achievement. The presentation argues for using strong evidence from research to change the discussion on marijuana from complicated to simple and from negative to positive. It provides sample messages focused on how marijuana use could negatively impact things people care about like education, employment, and highway safety.
This document provides a summary of a presentation on the risks of medical marijuana and marijuana legalization. It begins with disclosures from the presenters and outlines six learning objectives. It then discusses concerns that marijuana is addictive, especially for those who start using it early, and impacts adolescent brain development. The document notes the lack of evidence that marijuana is effective for the conditions it is claimed to treat. It also discusses the risks of increased diversion of marijuana to youth and greater social acceptance of marijuana use negatively impacting public health. The document concludes with messages on how to discuss these issues with the public.
This document summarizes a presentation on engaging physicians in prevention efforts to address the opioid epidemic. It was presented by Yngvild Olsen and included the following key points:
1. Multiple policies like PDMPs, medication-assisted treatment, and naloxone access need to work together to reduce opioid misuse and overdoses.
2. Programs that educate physicians about prescription drug abuse and its link to heroin, and engage them in prevention, screening, and treatment can help address the epidemic.
3. Expanding access to evidence-based treatment with medications like buprenorphine and naloxone, combined with behavioral therapies, can help manage opioid addiction as a chronic disease
The Above the Influence (ATI) campaign was created by the Office of National Drug Control Policy to educate youth about substance abuse. It delivers prevention messages nationally and locally to target 12-17 year olds, when they are most vulnerable to drug use. Studies show that youth exposed to ATI advertising are more likely to have anti-drug beliefs and feel the campaign speaks to them. The campaign shares its message through advertisements, downloadable resources, and on Facebook to encourage youth to stay drug free.
Your Health at Hand Survey: Perceptions of Over-the-Counter Medicine in the U.S.Your Health at Hand
The document summarizes the results of a survey on perceptions of over-the-counter (OTC) medicines in the US. The survey involved 1000 US consumers and 500 US physicians. It found that both consumers and physicians view OTC medicines as an important part of healthcare. Specifically, OTC medicines help empower consumers to care for minor ailments without needing a doctor's visit. They also help reduce the burden on medical professionals by treating minor issues without an office visit. Both groups generally trust that OTC medicines are effective and safe for treating minor ailments.
Trip project - engaging youth in developing harm reduction programsyouthrise
This document summarizes the TRIP! Project, a harm reduction program for youth who use drugs. TRIP! was founded in 1995 by youth for youth. They conduct outreach at festivals and advocate for harm reduction. The majority of those served are under 19 and use drugs at higher rates than general youth. TRIP! aims to provide non-judgmental education to keep youth safe and treat drug use as a health rather than legal issue. Evaluation found the program improved knowledge around safer drug use and sex. The document calls for supporting youth harm reduction programs to address issues like unsafe sex and sharing of drug equipment.
EVERFI Webinar: Addressing Prescription Drug Abuse on CampusMichele Collu
This document discusses addressing prescription drug abuse on college campuses. It begins by outlining the scope of the problem, noting that while the US makes up 5% of the world's population, it consumes 75% of the world's prescription drugs. Contributing factors to misuse include easy access to medications, misperceptions about safety, and direct-to-consumer drug advertising. The document then defines misuse and outlines the most commonly abused drug types - opioids, stimulants, and depressants. It presents data on misuse rates among college students and 18-25 year olds. Finally, it discusses prevention strategies including information dissemination, skill building, problem identification and referral services, environmental approaches, and campus-
Pitch Your Pills - Environmental Issues associated with prescription drug dis...wdmorgan
Pitch Your Pills overview at Florida Department of Environmental Protection for METRA, May 8, 2013. Learn more at seminolepreventioncoalition.org/pitchyourpills Presentation addressed the environmental issues associated with prescription drug disposal and providing an overview of Pitch Your Pills as a model campaign to implement permanent prescription drug disposal boxes. Led by William Morgan
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
This document summarizes a conference on examining prescription drug abuse across America. It discusses the growth of prescription drug overdose deaths, the impact of non-medical prescription drug use including billions in health care costs, and how prescription drug abuse affects people of all ages. The document outlines a national prescription drug abuse prevention strategy including education, prescription drug monitoring programs, and safe drug disposal. It emphasizes that collaboration between organizations and communities is key to addressing this complex issue.
This document summarizes an education and advocacy track on parents and naloxone presented at a conference. It introduces Joanne Peterson from Learn to Cope, an organization that provides support and resources to families affected by addiction. It outlines the goals of Learn to Cope, including educating communities about drug dangers and solutions. Data is presented showing the large number of people Learn to Cope has helped and its pilot program training parents to distribute naloxone kits has helped reduce overdose deaths in Massachusetts.
Preventing teen abuse of prescriptions and over theraynaandyailka
This document discusses preventing teen abuse of prescription and over-the-counter medications. It outlines a mission and goals to educate stakeholders on risk factors for teen abuse and significantly reduce abuse among teens aged 13-19. Objectives include better understanding trends in teen medication abuse, increasing parent-teen communication, and reducing unattended medications. Statistics show increasing rates of teen prescription drug abuse. Efforts to address the issue include prescription drug monitoring programs, take-back initiatives, and educating parents, physicians, and communities. Challenges include getting families, physicians, and authorities adequately involved in prevention.
National Rx Drug Abuse Summit, April 2-4, 2013. General Session presentation, "Prevention and Prosecution," Frances M. Harding, Director, Center for Substance Abuse Prevention, SAMHSA
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
Community pharmacists are well positioned to help address the growing problem of opioid and benzodiazepine addiction but face challenges. Early identification of at-risk patients, supportive benefit structures, and intervention training could empower pharmacists. While many recognize their responsibility, behavioral engagement in prevention is often lacking due to practice barriers, lack of patient information, and fear of responses. Standardizing communication expectations and screening tools could help pharmacists better fulfill their role on the treatment team.
I understand that I will be assigned a group assistant who will check in with me weekly to discuss my progress and goals. I agree to be honest with my
assistant about my substance use and high-risk behaviors. I understand that my assistant will share information with my treatment team if I disclose plans to harm
myself or others or if I report using substances in a way that puts my health or safety at risk.
Confidentiality I understand that what is said in group stays in group. I will not share other group members’ personal information outside of group. However, I understand
that my group leaders are mandated reporters and will share information with my treatment team or authorities if safety is a concern.
Safety I agree to
I N J U R Y P R E V E N T I O NAnna ValdeWalden UnFo.docxwilcockiris
Prescription drug misuse, especially of opioids and stimulants, is increasing among adolescents. Availability of these drugs has increased dramatically with over 45 million prescriptions for stimulants and over 209 million for opioids being written in 2010. Many teens have access to these drugs from their parents' medicine cabinets. While some believe prescription drugs are safer than illicit drugs, they are a major contributor to drug overdose deaths. Emergency nurses can help by educating patients and communities on proper storage, disposal and risks of misuse, ensuring prescription drug monitoring programs are used, and developing prescribing guidelines.
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine Global Medical Cures™
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
The document outlines state responses to prescription drug and heroin abuse presented at an advocacy track session. It includes presentations from officials in Arizona, Virginia, and New Mexico on their state's strategies. Arizona's presentation focuses on the state's prescriber report cards. Virginia's presentation discusses the governor's task force recommendations and a new health and criminal justice data committee. New Mexico's presentation describes the state's high overdose rates and model of stakeholder collaboration to reduce overdose deaths.
The document summarizes key findings from a survey of over 1,600 young adults aged 18-25 on trends in prescription stimulant misuse and abuse. Some of the main findings include:
- 17% of respondents reported misusing or abusing prescription stimulants without a valid prescription. Rates were higher among college students (20%) than non-students (15%).
- Motivations for misuse included improving academic or work performance and staying awake. Misuse was also connected to managing social and busy lifestyles.
- The majority of misusers sourced stimulants from friends who had valid prescriptions. Over half of prescribed respondents reported being asked to share or sell their medication.
Critique of Australian National Drugs Campaign (Media Effectiveness Research)AzmiSuhaimi
The National Drugs Campaign by the Australian Government aimed to reduce illicit drug use among young Australians over 10 years through 4 phases targeting youths and parents. Phase 3 (2007) built on earlier phases and targeted youths aged 13-24, parents of 8-17 year olds, and social organizations. Formative research involved surveys and literature review on drug harms. The outreach strategy used TV, print, and online ads plus booklets. Evaluative surveys found high campaign awareness and recognition among youths and parents, and that it influenced attitudes and increased parent-child drug discussions. Critiques noted the research relied heavily on past data and some target groups were not addressed or evaluated.
The document discusses the growing heroin addiction epidemic in the United States. It notes that prescription opioid misuse has led many Americans to turn to heroin and that overdose deaths have more than tripled since 2010. It provides information on prevention and treatment efforts, including expanding access to the overdose reversal drug naloxone and increasing medically-assisted treatment programs. The document also discusses Walgreens' efforts to install safe drug disposal kiosks and make naloxone available without a prescription to help address the crisis.
This document provides a summary of a presentation on translating the science on marijuana into effective public health messages. The presentation aimed to understand the latest science on marijuana use and how to frame prevention messages. It identifies concerns related to marijuana use and legalization such as addiction, impaired driving, and negative impacts on adolescent brain development and academic achievement. The presentation argues for using strong evidence from research to change the discussion on marijuana from complicated to simple and from negative to positive. It provides sample messages focused on how marijuana use could negatively impact things people care about like education, employment, and highway safety.
This document provides a summary of a presentation on the risks of medical marijuana and marijuana legalization. It begins with disclosures from the presenters and outlines six learning objectives. It then discusses concerns that marijuana is addictive, especially for those who start using it early, and impacts adolescent brain development. The document notes the lack of evidence that marijuana is effective for the conditions it is claimed to treat. It also discusses the risks of increased diversion of marijuana to youth and greater social acceptance of marijuana use negatively impacting public health. The document concludes with messages on how to discuss these issues with the public.
This document summarizes a presentation on engaging physicians in prevention efforts to address the opioid epidemic. It was presented by Yngvild Olsen and included the following key points:
1. Multiple policies like PDMPs, medication-assisted treatment, and naloxone access need to work together to reduce opioid misuse and overdoses.
2. Programs that educate physicians about prescription drug abuse and its link to heroin, and engage them in prevention, screening, and treatment can help address the epidemic.
3. Expanding access to evidence-based treatment with medications like buprenorphine and naloxone, combined with behavioral therapies, can help manage opioid addiction as a chronic disease
The Above the Influence (ATI) campaign was created by the Office of National Drug Control Policy to educate youth about substance abuse. It delivers prevention messages nationally and locally to target 12-17 year olds, when they are most vulnerable to drug use. Studies show that youth exposed to ATI advertising are more likely to have anti-drug beliefs and feel the campaign speaks to them. The campaign shares its message through advertisements, downloadable resources, and on Facebook to encourage youth to stay drug free.
Your Health at Hand Survey: Perceptions of Over-the-Counter Medicine in the U.S.Your Health at Hand
The document summarizes the results of a survey on perceptions of over-the-counter (OTC) medicines in the US. The survey involved 1000 US consumers and 500 US physicians. It found that both consumers and physicians view OTC medicines as an important part of healthcare. Specifically, OTC medicines help empower consumers to care for minor ailments without needing a doctor's visit. They also help reduce the burden on medical professionals by treating minor issues without an office visit. Both groups generally trust that OTC medicines are effective and safe for treating minor ailments.
Trip project - engaging youth in developing harm reduction programsyouthrise
This document summarizes the TRIP! Project, a harm reduction program for youth who use drugs. TRIP! was founded in 1995 by youth for youth. They conduct outreach at festivals and advocate for harm reduction. The majority of those served are under 19 and use drugs at higher rates than general youth. TRIP! aims to provide non-judgmental education to keep youth safe and treat drug use as a health rather than legal issue. Evaluation found the program improved knowledge around safer drug use and sex. The document calls for supporting youth harm reduction programs to address issues like unsafe sex and sharing of drug equipment.
EVERFI Webinar: Addressing Prescription Drug Abuse on CampusMichele Collu
This document discusses addressing prescription drug abuse on college campuses. It begins by outlining the scope of the problem, noting that while the US makes up 5% of the world's population, it consumes 75% of the world's prescription drugs. Contributing factors to misuse include easy access to medications, misperceptions about safety, and direct-to-consumer drug advertising. The document then defines misuse and outlines the most commonly abused drug types - opioids, stimulants, and depressants. It presents data on misuse rates among college students and 18-25 year olds. Finally, it discusses prevention strategies including information dissemination, skill building, problem identification and referral services, environmental approaches, and campus-
Pitch Your Pills - Environmental Issues associated with prescription drug dis...wdmorgan
Pitch Your Pills overview at Florida Department of Environmental Protection for METRA, May 8, 2013. Learn more at seminolepreventioncoalition.org/pitchyourpills Presentation addressed the environmental issues associated with prescription drug disposal and providing an overview of Pitch Your Pills as a model campaign to implement permanent prescription drug disposal boxes. Led by William Morgan
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
This document discusses the role of health departments in preventing neonatal abstinence syndrome (NAS). It notes that NAS rates have increased significantly in recent years, disproportionately affecting women. Health departments engage in surveillance to monitor NAS trends, partner with other organizations, support treatment and recovery programs, and provide education to prevent NAS, which is entirely preventable. The document outlines specific strategies health departments use across these areas to address the opioid epidemic and protect maternal and infant health.
The document discusses the opioid crisis in the United States, including rising rates of prescription opioid misuse and abuse, as well as heroin use and overdose deaths. It outlines how research can help address this crisis through developing less abusable analgesics, expanding access to treatment medications like naloxone and buprenorphine, and exploring new treatment approaches such as immunotherapies and precision medicine targeting genetic factors. The National Institute on Drug Abuse is supporting these research efforts and working to disseminate findings to improve prevention and intervention programs.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
This presentation covered multi-media prevention strategies for issues like prescription drug overdoses. It discussed the CDC's digital Rx drug prevention campaign, best practices for digital messaging, and programs using expectancy challenge theory and media literacy education in schools. Presenters included representatives from the CDC, Media Literacy for Prevention, and the Hanley Center Foundation who discussed their work developing and implementing digital communications and single-session prevention programs.
This document discusses strategies for reducing buprenorphine diversion and pill mills while improving access to treatment. It notes that limiting access to buprenorphine treatment is associated with increased diversion, while expanded access to quality treatment decreases diversion and overdose deaths. The document recommends educating prescribers, using medically-derived prescribing standards, ensuring adequate insurance coverage of safe prescribing practices, and addressing diversion risks for other controlled medications. It argues against onerous new regulations that could limit treatment access. The goal is to identify and support high-quality treatment while prosecuting criminal operations.
This document summarizes a presentation on linking and mapping prescription drug monitoring program (PDMP) data. It discusses the benefits of linking PDMP data to clinical data, including improving patient safety, evaluating prescribing decisions, and assessing the impact of PDMP interventions. It describes challenges with linking data, such as obtaining consent and negotiating data use agreements. It also discusses Washington State's MAPPING OPIOID AND OTHER DRUG ISSUES (MOODI) tool, which integrates PDMP data with other databases to map and target treatment and overdose prevention efforts at the community level.
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
This document discusses workplace issues related to prescription drug abuse and strategies for prevention. It begins with introductions of the presenters and moderators. The learning objectives are then outlined as understanding challenges of prescription drug abuse in the workplace, identifying prevention strategies, and describing programs available through SAMHSA. The document then covers topics such as the scope of prescription drug misuse among workers, risks to the workplace, prevention strategies employers can consider, and available resources from SAMHSA.
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
This document discusses a presentation on pharmacy burglary, robbery, and diversion of prescription drugs. The presentation covers trends in prescription drug diversion, particularly those involving robbery and burglary of pharmacies. It identifies preventative measures to enhance pharmacy security and safety. Strategies to reduce pharmacy crimes are outlined. The offender perspective is examined based on interviews with convicted offenders. Routine activities theory is discussed as relating to suitable targets, capable guardians, and motivated offenders. Partnerships between regulatory agencies and law enforcement are emphasized as key to prevention efforts.
Linking and mapping PDMP data can provide several benefits but also faces challenges. Linking PDMP and clinical data allows for evaluating the impact of PDMP interventions on outcomes and prescribing decisions. However, obtaining permissions and data is difficult due to legal and resource barriers. Mapping PDMP data using GIS tools in Washington identified areas for targeting overdose prevention efforts by visualizing patterns in prescribing risks, treatment availability, and overdoses. Stakeholders used these maps to guide education and funding decisions. Sustaining these tools requires ongoing funding and expanding included data sources.
This document discusses drug court models and the role of law enforcement in drug courts. It begins with introductions from presenters and outlines learning objectives about explaining drug court operations and benefits, how law enforcement can utilize drug courts, and identifying best practices. The following sections provide details on drug court models, including how they integrate treatment into the justice system using a non-adversarial approach. Key components of drug courts are outlined, and presenters discuss issues like prescription drug and heroin abuse as well as outcomes from drug courts in reducing recidivism and saving money. Law enforcement can play roles in prevention, addressing domestic violence, and targeting the right populations for drug court involvement through assessment.
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
This document discusses neonatal abstinence syndrome (NAS) and universal maternal drug testing. It provides background information on NAS including trends showing large increases in incidence and costs associated with NAS. It outlines objectives related to describing NAS trends, identifying legislative activities impacting NAS, describing family planning for women in substance abuse treatment, and explaining a hospital program using universal drug testing. The document then covers topics including NAS symptoms, incidence and geographic trends, costs of NAS, opioid use in women of childbearing age, unintended pregnancy rates, contraceptive use among opioid users, and maternal drug exposure sources.
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
This document discusses recovery ready ecosystems and recovery community organizations. It introduces presenters from Young People in Recovery and Hope House Treatment Track who will discuss interventions, prevention, and recovery programs. Examples of Young People in Recovery chapters, programs, and services are provided, including employment workshops, education workshops, housing workshops, and recovery support services. The document also discusses recovery community organizations and initiatives in Texas and Georgia, such as the Association of Persons Affected by Addiction in Dallas and the Georgia Council on Substance Abuse.
This document summarizes a presentation on health plan involvement in safe prescribing. It includes:
1) Presentations from medical experts on prescription drug abuse trends from medical examiner data and a tribal health system's safe prescribing program.
2) A discussion of health plan policies to reduce "red flag" medication combinations like opioids plus benzodiazepines through prior authorization, formulary changes, and provider restrictions.
3) Examples of one health plan's implementation of policies like restricting methadone prescriptions to pain specialists and removing carisoprodol from its formulary.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
1. Medicine Abuse
Awareness Week:
Presentation to the
National Rx Abuse Summit
April 10, 2012
2. Real Danger
Abusing prescription (Rx) and
over-the-counter (OTC) drugs
can be just as
dangerous, addictive and
even deadly as using ‘street’ drugs
3. Rx/OTC Abuse
Every day, 2,500 teens
abuse a prescription drug
for the first time
4. Rx/OTC Medicines Being Abused
• Rx pain relievers (Vicodin, OxyContin)
• Rx stimulants (Adderall, Ritalin)
• Rx tranquilizers/sedatives (Xanax, Valium)
• OTC cough/cold with ‘DXM’ (Robitussin,
Coricidin). Rx cough with codeine.
We must address the behavior of
intentionally abusing medicines
5. Medicine Abuse is “Normalized”
in Teen Culture
• 1 in 3 teens report having a close friend who
abuses Rx pain relievers to get high
• 1 in 5 report abusing an Rx medicine
6. Key Factors Driving Teen Medicine Abuse
• Misperceptions that abusing medicine is not
dangerous (safer than “street drugs”)
• Ease of access via medicine cabinets at home
or friend’s house, own or other person’s
prescriptions
7. What about parents’ perceptions?
• Street drugs are generally considered more
dangerous
• Parents are less familiar with “pills” – they
often have no frame of reference since these
types of drugs of abuse didn’t exist in their youth
• There’s a lack of urgency around Rx-OTC
8. Parent/Kid Conversation
• Only 1 in 5 (20%) teens report that their
parents have never talked to them about
alcohol or illegal drugs
• Half of teens (51%) say their parents have
never talked to them about prescription drug
abuse
9. Prescription Drug Abuse in the Headlines
• White House Office of National Drug Control Strategy’s
2011 Prescription Drug Abuse Prevention Plan
• Surgeon General’s Call to Action on Rx Abuse
• Upcoming National Governor’s Association Policy
Academy
• Congressional Hearings
• Top Issue with State Attorneys General
• US Attorneys Conferences
• CDC Report
Everyone is calling for action and
now we need to mobilize and respond
10. How Should We Respond To The Crisis?
Raising Awareness and Taking Action
• Research-based initiative to educate parents, youth, patients,
and prescribers is needed to move the needle on medicine
abuse behavior and consequences
• The Partnership seeks to enlist all major organizations with a
stake–and an important role to play–in preventing all
categories of medicine abuse to join in a concerted effort and
national call to action
• All participants will have an opportunity to showcase their work
on medicine abuse prevention and join with others to deliver
two key messages:
– Clean out your medicine cabinets/Secure
your medications
– Talk to your kids about Rx abuse
11. CDC statistics on consequences
underscore the need for bold action
• Rx pain medication overdoses killed nearly 15,000
people in the US in 2008. This is more than 3 times the
4,000 people killed by these drugs in 1999.
• Quantity of prescription pain medications sold to
pharmacies, hospitals, and doctors’ offices was 4 times
larger in 2010 than in 1999.
• State death rates from drug overdoses (2008 data)
ranged from 27 deaths per 100,000 people in New
Mexico to 5.5 deaths per 100,000 people in Nebraska.
12. CDC statistics on consequences
underscore the need for bold action
• The cost of Rx abuse is estimated to be between $54 and
$72.5 BILLION each year. Also, the direct health care costs
for people who abuse Rx pain medications are eight times
higher than for those who don’t abuse these medications.
• And at the same time we are less equipped as a nation to
deal with this problem as the national prevention
infrastructure is crumbling:
• Safe and Drug Free Schools state grant program eliminated
• National Youth Anti-Drug Media Campaign eliminated
• SAMHSA block grant to states for prevention programs in jeopardy
• States and localities don’t have resources to
make up for the lost federal dollars
13. How Can We Change the
Public’s Behavior Around
Medicine Abuse?
15. National Youth Anti-Drug Media Campaign
First Half 2008
• Focus on prescription drug abuse – dedicated roughly
$14 million between February and July (with media
match = approximately $28 million)
• Campaign message: There’s a dangerous drug risk
to our teens that’s off our radar but under our
noses
• TV advertising schedule (launching in Super Bowl)
supplemented with print advertising, PR and drug
chain flyers stapled to prescriptions
16. National Youth Anti-Drug Media Campaign
First Half 2008
• Outreach to healthcare professionals and educators
(trade journals, “open letter” newspaper ads) and
community organizations, coalitions (CADCA
Strategizers)
• Heath Ledger dies – January 22, 2008
17. Television Advertising
• Partnership PSA (2007):
Parent-targeted message running in pro-bono media
• “Who’s More Dead?”
• National Youth Anti-Drug Media Campaign (2008):
Parent-targeted messages running in paid media + match
• “Drug Dealer”
• “All My Pills”
18. Awareness of Advertising – Teen Rx Abuse
Awareness levels from the pre- to post-launch periods
more than doubled from the
launch of the campaign
Up 116%
67%
31%
Post-launch
Pre-launch
N=3,200
N=1,100
Q.17: Have you seen any advertising about prescription drug abuse among teens recently? It may have been
anywhere. – Millward Brown Tracking
19. Parents’ Perceptions –
Prevalence of Teen Rx Abuse
Among those parents who are aware of advertising, perceptions of the prevalence of teen RX
abuse increased significantly from the pre- to post-launch periods
Up 10% 85%
77%
Pre-launch Post-launch
N=1,100 N=3,200
Q.19: How prevalent do you believe prescription drug abuse is among teens? - Millward Brown Tracking
20. Parents’ Beliefs –
Rx Abuse is a Serious Problem Among Teens
There has been a significant jump among parents who viewed the campaign who now believe
that prescription drug abuse is a serious problem among teens
Up 17% 59%
49%
Pre-launch Post-launch
N=1,100 N=3,200
Q.11 series: Prescription drug abuse is a serious problem among teens – Agree strongly / somewhat
Millward Brown Tracking
21. Parents’ Likelihood to Take Action
Among parents who saw the ads, a significant increase was also seen
in intention to take action against teen RX abuse Up 6%
Up 13% Up 12% Up 9% 88%
83%
77% 76% 77%
70%
68% 67%
Safeguard drugs Monitor prescription Properly dispose of Set clear rules for teens
at home drug quantities and old unused medicines about all drug use
control access including not sharing
medicines
Q.20: In the next month, how likely you are to take the following actions with respect to the prescription medicines in
your home? Zero means that you are extremely unlikely, five means you are neither likely nor unlikely and ten means
that you are extremely likely to take that action. --- Millward Brown Tracking
22. Challenges
• “Not My Kid” – a perennial challenge (the “disconnect”)
• Multiple components to the message:
• The dangers of abusing prescription drugs
• My kid is at risk
• The danger is actually in my medicine cabinet
• What can / should parents do?
• And a watchout: don’t demonize medicine
• There’s a dangerous drug risk to our teens that’s off
our radar but under our noses
• Danger: the comparison with illegal street drugs
• My kid: the innocent schoolboy
• Off our radar: the sly appropriation of legitimate medicine
for purposes of abuse, trading, selling
• Under our nose – print “medicine cabinet” ads
23. Rx Drugs Used Without Prescription
PRESCRIPTION
Have Used
28%
PARENTS
37%
TEENS
26a. Have you ever personally used a prescription drug that was not prescribed for you by a doctor?
Almost 3 out of 10 parents have taken an Rx drug
without a prescription
Partnership Study (2007): Cause for Concern
24. When it’s OK to give teen Rx drugs
27. In your opinion, in which of the following situations, if any, would be okay for a parent to give their teen a prescription drug that was not prescribed for him/her?
One-quarter (27%) believe there are certain situations when it
is ok to give an Rx that was not prescribed for him/her
Partnership Study (2007): Cause for Concern
25. Prescription drug given to teen
IPTIONS GIVEN TO TEEN
25. Have you ever given your teen a prescription drug that was not prescribed for him/her?
8% of parents have given their teen an Rx drug without a
doctor’s prescription
Partnership Study (2007): Cause for Concern
26. Call to Action:
Medicine Abuse
Awareness Week
One defined period in the Fall of 2012 in
which all major organizations with a stake in
preventing medicine abuse will join in a
national education effort and call to action.
27. Medicine Abuse Awareness Week
Objectives:
1) Raise awareness of the Rx abuse problem among
the general public, especially parents, and health
care professionals
2) Increase communication between parents and
teens about the risks of Rx abuse
3) Improve interaction between prescribers,
dispensers and patients
4) Improve at-home monitoring of medicine supply
5) Drive safe disposal of unused medicines via a
national “takeback” call to action
28. Medicine Abuse Awareness Week
Components:
1) Dedicated web destination with information and tools for
parents, healthcare providers and the general public, and
promoting a national take-back day
2) Intensive communications blitz aimed at (1) promoting
parent-teen conversations about the risks of Rx abuse and
(2) promoting monitoring and safe disposal of drugs
• Tagging DTC and other advertising
• Dedicated Campaign Advertising
• Social Media
• Point-of-sale education/materials at leading pharmacies
• Major PR initiative enlisting government leaders,
public health professionals and industry
29. Medicine Abuse Awareness Week
Components:
3) Prescriber Education Initiative
Screeners, prescriber-patient agreements, video materials for waiting
rooms, etc.
4) National Takeback Day
5) Evaluation of Effectiveness
30. Importance of Large, Broad-Based Effort
• All of the organizations represented here today could
have a key role in the public relations efforts,
prescriber education initiatives and/or takeback day
• Having everyone work together would bring the
prevention messages to scale and show unity
• Good way to promote your organization's ongoing
efforts in this area and partner with people in new
ways
31. Strategic Partners
• Government Officials (Surgeon General, National
Governors Association, US Conference of Mayors,
State Legislators, etc.)
• Law Enforcement
• Medical Professional Organizations
• Public Health Organizations
• Drug Prevention Organizations
32. Discussion
• How can we get as many groups as possible
involved in this national effort?
• How can your group participate?
• How can we broaden the impact of Medicine
Abuse Awareness Week?
• Who else should be involved?